Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2025-12-24 @ 5:58 PM
NCT ID:
NCT00750568
Eligibility Criteria:
Inclusion Criteria:
* Children 2 to 18 years of age.
* Admission to the ICU with a diagnosis of status asthmaticus.
* The pediatric intensivist taking care of the patient has decided to initiate intravenous terbutaline therapy.
* An indwelling venous catheter or arterial catheter that was placed for routine ICU monitoring.
* Informed consent obtained from the patient's parents or legal guardian.
Exclusion Criteria:
* Existing cardiovascular disease.
* History of bronchopulmonary dysplasia.
* Prior inclusion in this study.
* Known hypersensitivity to terbutaline, or prior adverse event associated with terbutaline.
* Terbutaline use within 48 hours of initiation of the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
18 Years
Study:
NCT00750568
Study Brief:
Protocol Section:
NCT00750568